RxDoctor Payments DataLook up a doctor →

Addie Holcomb, NP

Gerontology · Gulfport, MSNPI 1942840368

Payments from drug & device makers

$6,722in general payments, 2019–2025

Across 323 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$715
  • Johnson & Johnson$608
  • Exelixis Inc.$539
  • Merck$453
  • Eisai Inc.$307
  • AstraZeneca$273
  • plus $4K from 49 others

What the payments were for

  • Food & beverage$6,55397%
  • Education$1693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,722 in reported general payments places this provider in the 90th percentile of 66 gerontology providers in Mississippi.

See all gerontology providers in Mississippi

Medicare billing

Part B allowed, 2024
$943
Medicare patients
12
Services billed
12

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide20$283,854
XareltoRivaroxaban17$11,489
Letrozole66$1,746
Oxycodone Hcl19$604
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$569
Gabapentin49$396
Bupropion Hcl SrBupropion Hcl12$363
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$363
Ondansetron Hcl25$329
Omeprazole33$307
Atorvastatin Calcium28$259
Duloxetine Hcl14$256
Mirtazapine32$249
Ondansetron OdtOndansetron12$249
Levothyroxine Sodium24$228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi$87$283,85420 claims
Johnson & JohnsonXarelto$608$11,48917 claims
Lilly USA, LLCOlanzapine$195$21511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 66 gerontology providers in Mississippi.

Other gerontology in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →